Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookStandard Treatment Guidelines (STG) and The National Essential Drug List for Tanzania (NEDLIT) (WHO; 1997; 210 pages)
View the documentFOREWORD
View the documentACKNOWLEDGMENTS
View the documentINTRODUCTION
close this folderStandard Treatment Guidelines (STG)
Open this folder and view contents1. GASTROINTESTINAL CONDITIONS
Open this folder and view contents2. RESPIRATORY DISEASES
Open this folder and view contents3. OBSTETRIC AND GYNAECOLOGICAL CONDITIONS AND CONTRACEPTION
Open this folder and view contents4. CARDIOVASCULAR DISEASES
close this folder5. MALARIA
View the document5.1 General Guidelines
View the document5.2 Uncomplicated Malaria, Chloroquine Sensitive
View the document5.3 Uncomplicated Malaria, Chloroquine resistant
View the document5.4 Malaria due to vivax/ovale
close this folder5.5 Complicated Malaria
View the document5.5.1 General measure
Open this folder and view contents6. SKIN DISEASES
Open this folder and view contents7. SEXUALLY TRANSMITTED INFECTIONS / DISEASES (STD)
Open this folder and view contents8. DENTAL AND ORAL CONDITIONS
Open this folder and view contents9. GENITO-URINARY DISEASES: KIDNEY CONDITIONS
Open this folder and view contents10. EAR, NOSE AND THROAT CONDITIONS
Open this folder and view contents11. EYE CONDITIONS
Open this folder and view contents12. TUBERCULOSIS AND LEPROSY
Open this folder and view contents13. MUSCULOSKELETAL CONDITIONS AND JOINT DISEASES
Open this folder and view contents14. METABOLIC AND ENDOCRINE SYSTEM CONDITIONS
Open this folder and view contents15. CENTRAL NERVOUS SYSTEM DISEASE CONDITIONS
Open this folder and view contents16. OTHER DISEASE CONDITIONS
Open this folder and view contents17. VIRAL INFECTIONS
Open this folder and view contents18. ALLERGIC REACTIONS
Open this folder and view contents19. NUTRITIONAL AND HAEMATOLOGIC CONDITIONS
Open this folder and view contents20. MALIGNANT DISEASE CONDITIONS
Open this folder and view contents21. INJURIES AND TRAUMA
View the document22. FOREIGN BODIES
View the document23. PAIN
View the document24. POISONING
View the document25. NORMAL LABORATORY VALUES
Open this folder and view contentsNATIONAL ESSENTIAL DRUG LIST
View the documentABBREVIATIONS AND SYMBOLS
 

5.5 Complicated Malaria

• Cerebral malaria
• Severe haemolytic anaemia
• Renal failure
• Severe haemoglobinuria
• Hyperparasitaemia (25 or greater in non-immune or parasites > 100/field in disc smear)


NOTE It is important that therapy is initiated without delay at a district hospital but use discretion and guidelines in referring; Drug treatments assume all cases chloroquine resistant

 

Quinine (IV infusion) 10 mg/kg salt diluted in dextrose 5% given over 4 hours in a total volume of 5 - 10 ml/kg; followed by 10 mg/kg salt every 8 hours in adults and every 12 hours in children up to 4 doses then until the patient can swallow, then give for

Adult

Quinine (O) 600 mg (salt) every 8 hours to complete 7 days treatment.

Children

10 mg/kg (salt) as for adult

CAUTION

• The initial dose should be halved if patient had received quinine, quinidine or mefloquine during the previous 12-24 hours.

• Maintenance dose should be reduced three fold in patients with impaired renal function

• Pulse and blood pressure should be closely monitored during administration

• Rate of infusion be reduced if dysrhythmia occurs.

• Direct IV injection should NOT be given. Hypoglycaemia may occur after I.V administration of Quinine

• IM injection is less satisfactory but may be used to initiate therapy when facilities for IV infusion are NOT available.

The required dose should be divided equally between two sites (one in each anterior flight), Muscle necrosis and sterile abscesses may appear. If possible avoid IM Quinine injection.

In addition give

Pyrimethamine + Sulfadoxine (3 tablets, adult) as a single dose at the end of Quinine treatment

to previous sectionto next section

Please provide your feedback
Abbreviations
English  |  French